# Pietro's Fight

Pietro's Fight is a Private Equity based in Staten Island, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Staten Island, United States
- **Region:** North America
- **Address:** 50 Blackhorse Court, Staten Island, NY 10306, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** pietrosfight.org
- **LinkedIn:** https://www.linkedin.com/company/pietrosfight-org

## Regulatory record

- **Reports private funds:** No

## About

Dayna and Manni Scarso founded Pietro's Fight after their son, born May 14, 2009, was diagnosed with Duchenne Muscular Dystrophy, the most common fatal genetic disorder among children. The organization operates from a clear personal mandate: convert a family's urgent search for a cure into a funding engine for drug development and awareness. The entity deploys capital primarily into venture-stage therapeutic research targeting Duchenne. Its model blends grant-making with disease-awareness campaigns, positioning the organization as both a funder and an advocacy platform. The group backed work that contributed to the FDA's 2016 approval of Exondys 51, a milestone treatment for a subset of DMD patients (per the firm website). The geographic footprint is rooted in the United States, with operations and community engagement concentrated in the New York metropolitan area. Team size and total deployment figures remain undisclosed. The Scarsos drive the organization alongside an advisory structure listed on its website. The group runs an active events calendar — raffles and an annual 5K run — to sustain fundraising, and news updates from September 2022 confirm public celebration of incremental regulatory wins tied to the research it supports. Unlike a pure grant-making foundation, Pietro's Fight operates with the hands-on urgency of a family office allocating to a single-disease thesis. Its structural differentiator is this dual identity: a parent-led funding vehicle that blends donor-directed research bets with direct patient-community mobilization, a model where the limited partners are essentially the affected families and their networks.

## Sectors

- Healthcare Services

## People

- Dayna Scarso — Co-Founder
- Manni Scarso — Co-Founder

## Questions

### How does Pietro's Fight deploy its capital?

Pietro's Fight directs funding toward early-stage research and drug development for Duchenne Muscular Dystrophy. The organization supported work that contributed to the FDA's approval of Exondys 51 in 2016, demonstrating a targeted, milestone-driven allocation approach. Its model combines direct research funding with patient and public awareness campaigns.

### Is Pietro's Fight a grant-making foundation or an investment vehicle?

It functions as a venture-philanthropy hybrid. Rather than operating purely as a grant-making charity, the organization takes a hands-on role in funding translational research, with tangible outcomes such as advancing a drug toward FDA approval. This blurring of advocacy and targeted research funding sets it apart from a traditional foundation.

### Who makes the funding decisions at Pietro's Fight?

Founders Dayna and Manni Scarso lead the organization. They work with an advisory group listed on the firm's website, though specific investment committee structures or outside advisors are not publicly disclosed. Decision-making flows from the founders' direct, parent-led urgency to find a cure.

### Does Pietro's Fight have any assets under management or a formal fund structure?

No AUM or formal fund structure is publicly disclosed. The entity raises money through events, direct donations, and community fundraising. Its capital flows into research grants and advocacy rather than a pooled investment vehicle with limited partners.

## Related profiles

- [Pierson Wealth Management](https://altss.com/profile/pierson-wealth-management)
- [PIF VC](https://altss.com/profile/pif-vc)

---

Last updated: 2026-07-06T00:37:11.736Z

Canonical page: https://altss.com/profile/pietro-s-fight

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology